Expand ADPT Menu

ADPT Stock Summary and Trading Ideas (Adaptive Biotechnologies | NASDAQ:ADPT)

Charts for Today's Stock Price and Implied Volatility in Adaptive Biotechnologies

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for ADPT by Theoretical Edge and Win Rates


Trading Statistics

Key Ratios

Adaptive Biotechnologies (ADPT) Frequently Asked Questions

What does Adaptive Biotechnologies do?

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

What symbol and exchange does Adaptive Biotechnologies stock trade?

Adaptive Biotechnologies trades on the NASDAQ stock market under the symbol ADPT.

What is Adaptive Biotechnologies stock price doing today?

As of June 18, 2024, ADPT stock price declined to $3.13 with 160,680 million shares trading.

What is Adaptive Biotechnologies's Beta?

ADPT has a beta of 3.16, meaning it tends to be more sensitive to market movements. ADPT has a correlation of 0.23 to the broad based SPY ETF.

How much is Adaptive Biotechnologies worth?

ADPT has a market cap of $461.26 million. This is considered a Small Cap stock.

How much money does Adaptive Biotechnologies make?

Last quarter Adaptive Biotechnologies reported $42 million in Revenue and -$.33 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.01.

What is the highest and lowest price Adaptive Biotechnologies traded in the last 3 year period?

In the last 3 years, ADPT stock traded as high as $43.40 and as low as $2.28.

What are the top ETFs holding Adaptive Biotechnologies?

The top ETF exchange traded funds that ADPT belongs to (by Net Assets): ARKG, VTI, VB, IWM, VBK.

Is Adaptive Biotechnologies (ADPT) a good investment?

ADPT has underperformed the market in the last year with a price return of -62.7% while the SPY ETF gained +25.8%. ADPT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -3.4% and -5.4%, respectively, while the SPY returned +7.5% and +3.8%, respectively.

What is the support and resistance for Adaptive Biotechnologies (ADPT) stock price?

ADPT support price is $2.98 and resistance is $3.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADPT stock will trade within this expected range on the day.